Surgery Partners, Inc. (NASDAQ:SGRY) Receives Consensus Rating of “Moderate Buy” from Analysts

Surgery Partners, Inc. (NASDAQ:SGRY) has earned an average recommendation of “Moderate Buy” from the nine analysts that are currently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average twelve-month target price among brokers that have covered the stock in the last year is $36.63.

A number of brokerages have recently commented on SGRY. Bank of America assumed coverage on shares of Surgery Partners in a research report on Monday, December 16th. They issued a “buy” rating and a $30.00 price objective for the company. Royal Bank of Canada reiterated an “outperform” rating and issued a $35.00 price target on shares of Surgery Partners in a report on Tuesday, March 25th. Macquarie decreased their price objective on Surgery Partners from $34.00 to $33.00 and set an “outperform” rating on the stock in a report on Tuesday, March 11th. Finally, JPMorgan Chase & Co. dropped their target price on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a research note on Tuesday, December 3rd.

Insider Transactions at Surgery Partners

In related news, insider Harrison R. Bane sold 56,315 shares of the firm’s stock in a transaction that occurred on Friday, February 7th. The shares were sold at an average price of $25.64, for a total value of $1,443,916.60. Following the transaction, the insider now owns 107,037 shares in the company, valued at approximately $2,744,428.68. This trade represents a 34.47 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Marissa Brittenham sold 3,156 shares of Surgery Partners stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $24.09, for a total transaction of $76,028.04. Following the transaction, the insider now directly owns 63,408 shares in the company, valued at approximately $1,527,498.72. This trade represents a 4.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 106,622 shares of company stock worth $2,717,860 in the last three months. 2.30% of the stock is currently owned by company insiders.

Institutional Trading of Surgery Partners

Several large investors have recently added to or reduced their stakes in SGRY. FMR LLC boosted its position in shares of Surgery Partners by 3.1% in the third quarter. FMR LLC now owns 18,311,867 shares of the company’s stock worth $590,375,000 after buying an additional 546,869 shares during the period. Janus Henderson Group PLC boosted its holdings in Surgery Partners by 110.2% in the 4th quarter. Janus Henderson Group PLC now owns 11,554,845 shares of the company’s stock worth $244,616,000 after acquiring an additional 6,057,477 shares during the period. Vanguard Group Inc. grew its position in Surgery Partners by 2.3% in the fourth quarter. Vanguard Group Inc. now owns 7,618,404 shares of the company’s stock valued at $161,282,000 after acquiring an additional 172,271 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Surgery Partners by 18.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,577,861 shares of the company’s stock valued at $75,739,000 after purchasing an additional 563,812 shares during the period. Finally, King Street Capital Management L.P. lifted its position in shares of Surgery Partners by 93.1% during the fourth quarter. King Street Capital Management L.P. now owns 2,800,000 shares of the company’s stock worth $59,276,000 after purchasing an additional 1,350,000 shares in the last quarter.

Surgery Partners Stock Down 0.7 %

Surgery Partners stock opened at $23.95 on Monday. Surgery Partners has a fifty-two week low of $19.50 and a fifty-two week high of $33.97. The firm has a market capitalization of $3.06 billion, a price-to-earnings ratio of -49.90, a price-to-earnings-growth ratio of 19.21 and a beta of 2.73. The stock’s fifty day moving average is $24.31 and its two-hundred day moving average is $25.52. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings data on Monday, March 3rd. The company reported $0.39 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.01. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The firm had revenue of $864.40 million for the quarter, compared to analysts’ expectations of $828.09 million. Analysts predict that Surgery Partners will post 0.67 EPS for the current fiscal year.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.